share_log

SUNSHINE BIOPHARMA INC C/WTS (TO PUR COM) | 8-K: SUNSHINE BIOPHARMA REPORTS 2023 FIRST QUARTER RESULTS: REVENUES UP 2,100%

SEC ·  May 12, 2023 04:59
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more